The following In House Advisor guidance note provides comprehensive and up to date legal information covering:
Click here to download the latest Pharmaceutical Antitrust report 2019, published by Getting the Deal Through.
The following jurisdictions are covered in this report:
Brazil; Bulgaria; Canada; China; European Union; Finland; France; Germany; India; Japan; Portugal; Romania; Spain; Turkey; United Kingdom; United States
The set of questions relating to the topic of Pharmaceutical Antitrust and answered by the guide for each jurisdiction covered include:
What is the applicable regulatory framework for the authorisation, pricing and marketing of pharmaceutical products, including generic drugs?
Which authorities are entrusted with enforcing these rules?
Are drug prices subject to regulatory control?
Is the distribution of pharmaceutical products subject to a specific framework or legislation? Do the rules differ depending on the distribution channel?
Which aspects of the regulatory framework are most directly relevant to the application of competition law to the pharmaceutical sector?
What are the main competition law provisions and which authorities are responsible for enforcing them?
What actions can competition authorities take to tackle anticompetitive conduct or agreements in the pharmaceutical sector and what remed
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234